The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine model

Pathophysiology

Volumn 22, Issue 1, 2015, Pages 31-37

  Brunson, Jerry L ^a,b   Becker, Felix ^a,c   Stokes, Karen Y ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cytomegalovirus; Dextran sodium sulfate; Disease activity index; Gross bleeding; Inflammation; Ulcerative colitis

Indexed keywords

MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; LOOSE FECES; MOUSE; MURINE MODEL; NONHUMAN; OCCULT BLOOD; PERSISTENT VIRUS INFECTION; RECTUM HEMORRHAGE; WEIGHT REDUCTION;

EID: 84922853574     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2014.11.001     Document Type: Article

References (30)

1. Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J. Gastroenterol.: WJG 2006, 12:6102-6108.
2. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
3. Burisch J., Munkholm P. Inflammatory bowel disease epidemiology. Curr. Opin. Gastroenterol. 2013, 29:357-362.
4. Danese S., Fiocchi C. Ulcerative colitis. N. Engl. J. Med. 2011, 365:1713-1725.
5. Danese S., Sans M., Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 2004, 3:394-400.
6. Lamps L.W., Madhusudhan K.T., Havens J.M., Greenson J.K., Bronner M.P., Chiles M.C., Dean P.J., Scott M.A. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am. J. Surg. Pathol. 2003, 27:220-227.
7. Davis W.C., Madsen-Bouterse S.A. Crohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue. Vet. Immunol. Immunopathol. 2012, 145:1-6.
8. Greenstein R.J. Is Crohn's disease caused by a mycobacterium?. Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect. Dis. 2003, 3:507-514.
9. Criscuoli V., Rizzuto M.R., Cottone M. Cytomegalovirus and inflammatory bowel disease: is there a link?. World J. Gastroenterol.: WJG 2006, 12:4813-4818.
10. Lawlor G., Moss A.C. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?. Inflamm. Bowel Dis. 2010, 16:1620-1627.
11. D'Ovidio V., Vernia P., Gentile G., Capobianchi A., Marcheggiano A., Viscido A., Martino P., Caprilli R. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J. Clin. Virol. 2008, 43:180-183. (the official publication of the Pan American Society for Clinical Virology).
12. Wakefield A.J., Fox J.D., Sawyerr A.M., Taylor J.E., Sweenie C.H., Smith M., Emery V.C., Hudson M., Tedder R.S., Pounder R.E. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J. Med. Virol. 1992, 38:183-190.
13. Al-Zafiri R., Gologan A., Galiatsatos P., Szilagyi A. Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol. Hepatol. 2012, 8:230-239.
14. Ayre K., Warren B.F., Jeffery K., Travis S.P. The role of CMV in steroid-resistant ulcerative colitis: a systematic review. J. Crohns Colitis 2009, 3:141-148.
15. Cottone M., Pietrosi G., Martorana G., Casa A., Pecoraro G., Oliva L., Orlando A., Rosselli M., Rizzo A., Pagliaro L. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am. J. Gastroenterol. 2001, 96:773-775.
16. Nguyen M., Bradford K., Zhang X., Shih D.Q. Cytomegalovirus reactivation in ulcerative colitis patients. Ulcers 2011 2011, 282507. 10.1155/2011/282507.
17. Powell R.D., Warner N.E., Levine R.S., Kirsner J.B. Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am. J. Med. 1961, 30:334-340.
18. Whittem C.G., Williams A.D., Williams C.S. Murine colitis modeling using dextran sulfate sodium (DSS). J. Visualized Exp. 2010, 35:e1652. 10.3791/1652.
19. Mariguela V.C., Chacha S.G., Cunha Ade A., Troncon L.E., Zucoloto S., Figueiredo L.T. Cytomegalovirus in colorectal cancer and idiopathic ulcerative colitis. Revista do Instituto de Medicina Tropical de Sao Paulo 2008, 50:83-87.
20. de Maar E.F., Kleibeuker J.H., Boersma-van Ek W., The T.H., van Son W.J. Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients. Transpl. Int. 1996, 9:576-580. (official journal of the European Society for Organ Transplantation).
21. Onyeagocha C., Hossain M.S., Kumar A., Jones R.M., Roback J., Gewirtz A.T. Latent cytomegalovirus infection exacerbates experimental colitis. Am. J. Pathol. 2009, 175:2034-2042.
22. Melgar S., Karlsson A., Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G1328-G1338.
23. Khoretonenko M.V., Leskov I.L., Jennings S.R., Yurochko A.D., Stokes K.Y. Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses. Am. J. Pathol. 2010, 177:2134-2144.
24. Ebaugh F.G., Beeken W.L. Quantitative measurement of gastrointestinal blood loss. II. Determination of 24-hour fecal blood loss by a chemical photospectrometric technique. J. Lab. Clin. Med. 1959, 53:777-788.
25. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993, 69:238-249. (a journal of technical methods and pathology).
26. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., Meuwissen S.G., Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 1998, 114:385-391.
27. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350.
28. Matsumura K., Nakase H., Kosugi I., Honzawa Y., Yoshino T., Matsuura M., Kawasaki H., Arai Y., Iwashita T., Nagasawa T., Chiba T. Establishment of a novel mouse model of ulcerative colitis with concomitant cytomegalovirus infection: in vivo identification of cytomegalovirus persistent infected cells. Inflamm. Bowel Dis. 2013, 19:1951-1963.
29. Yan S.L., Russell J., Harris N.R., Senchenkova E.Y., Yildirim A., Granger D.N. Platelet abnormalities during colonic inflammation. Inflamm. Bowel Dis. 2013, 19:1245-1253.
30. Yoshida H., Granger D.N. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm. Bowel Dis. 2009, 15:1245-1255.